SCHEMBL5101468

SCHEMBL5101468

CN(C)C(=O)n1ccc2cc(Nc3cc(N)ncn3)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 2/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
CCNA2 P20248 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
CDK5R1 Q15078 1/20 0.41
CLK4 Q9HAZ1 2/20 0.40
TAOK1 Q7L7X3 1/20 0.40
EGFR P00533 5/20 0.39
KDR P35968 2/20 0.38
SCN9A Q15858 1/20 0.38
DOT1L Q8TEK3 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
PIK3CD O00329 1/20 0.36
ABL1 P00519 1/20 0.36
HCK P08631 1/20 0.36
SRC P12931 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5102204 0.91 CDK5 (0.41) CDK5CDK1CCNB1CCNA2CCNE1
SCHEMBL5104598 0.85 KDR (0.43) CDK5CDK1CCNB1CCNA2CCNE1
SCHEMBL5108427 0.84 KDR (0.41) CDK5CDK1CCNB1CCNA2CCNE1
SCHEMBL5115530 0.82 CDK5 (0.43) CDK5CDK1CCNB1CCNA2CCNE1
SCHEMBL5108434 0.81 S1PR1 (0.43) CDK5CDK1CCNB1CCNA2CCNE1
SCHEMBL5101265 0.80 KDR (0.52) CDK5CDK1CCNB1CCNA2CCNE1
SCHEMBL13999436 0.80 CDK5 (0.40) CDK5CDK1CCNB1CCNA2CCNE1
SCHEMBL5114869 0.79 KDR (0.41) CDK5CDK1CCNB1CCNA2CCNE1
SCHEMBL5115927 0.79 EGFR (0.43) EGFRKDRABL1SRCEPHB4
SCHEMBL13999502 0.77 EGFR (0.42) EGFRKDRABL1SRCEPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7468380-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-12-23 US disclosed
US-7468380-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-12-23 US disclosed
US-7468380-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-12-23 US disclosed
CN-100339376-C Nitrogen-containing aromatic ring derivatives EISAI CO LTD (JP) 2007-09-26 CN disclosed
US-20070004764-A1 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-01-04 US disclosed
US-20070004764-A1 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-01-04 US disclosed
US-20070004764-A1 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-01-04 US disclosed
US-7109219-B2 Nitrogen-containing aromatic derivatives EISAI CO., LTD. (JP) 2006-09-19 US disclosed
US-20060004029-A1 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-01-05 US disclosed
CN-1678607-A Nitrogen-containing aromatic ring derivatives EISAI CO LTD (JP) 2005-10-05 CN disclosed
US-20050187236-A1 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-08-25 US disclosed
EP-1522540-A1 AZAARENE DERIVATIVES Eisai Co., Ltd. (JP) 2005-04-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004029-A1 Nitrogen-containing aromatic derivatives NR0B2, NR0B1, NR4A1 CDK5 1725/4885CDK1 1042/4885CCNB1 737/4885
US-20050187236-A1 Nitrogen-containing aromatic derivatives NR0B2, NR0B1, NR4A1 CDK5 1725/4885CDK1 1042/4885CCNB1 737/4885
US-20070004764-A1 Nitrogen-containing aromatic derivatives NR0B2, NR0B1, NR4A1 CDK5 1725/4885CDK1 1042/4885CCNB1 737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.